Login/Sign Up
₹20500*
MRP ₹25000
18% off
₹21250*
MRP ₹25000
15% CB
₹3750 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Manufacturer/Marketer address
Alcohol
Consult your doctor
It is not known if alcohol interacts with Adalipca 40 mg/0.8 ml Injection 1's. Please consult the doctor.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before receiving Adalipca 40 mg/0.8 ml Injection 1's. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Adalipca 40 mg/0.8 ml Injection 1's.
Driving
Not applicable
Adalipca 40 mg/0.8 ml Injection 1's will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
Adalipca 40 mg/0.8 ml Injection 1's should be used with caution if you have liver disease. Dose adjustment may be needed in patients with liver impairment.
Kidney
Caution
Adalipca 40 mg/0.8 ml Injection 1's should be used with caution if you have kidney disease. Dose adjustment may be needed in patients with liver impairment.
Children
Caution
Adalipca 40 mg/0.8 ml Injection 1's is not recommended in children below two years of age as safety and efficacy are not established. In children above two years of age, it will be administered by the pediatrician. Adalipca 40 mg/0.8 ml Injection 1's is used in children only for the treatment of juvenile idiopathic arthritis, paediatric Crohn’s disease, and uveitis.
Product Substitutes
Keep Refrigerated. Do not freeze.Prepaid payment required.
About Adalipca 40 mg/0.8 ml Injection 1's
Adalipca 40 mg/0.8 ml Injection 1's belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors that help reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, plaque psoriasis, and psoriatic arthritis. This medicine is also used in the treatment of Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and uveitis.
Adalipca 40 mg/0.8 ml Injection 1's consists of Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused by various autoimmune diseases.
Adalipca 40 mg/0.8 ml Injection 1's may cause certain side effects such as nausea, headache, back pain, upper respiratory tract infections, vision problems, dizziness, pale skin, numbness, chest pain, rash, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Adalipca 40 mg/0.8 ml Injection 1's is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.
Adalipca 40 mg/0.8 ml Injection 1's should be avoided if you are allergic to any of its components. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Adalipca 40 mg/0.8 ml Injection 1's may cause dizziness, so drive only if you are alert and focused. Adalipca 40 mg/0.8 ml Injection 1's should not be given to children under two years of age as safety has not been established. Consult the doctor if you are pregnant or breastfeeding.
Uses of Adalipca 40 mg/0.8 ml Injection 1's
Medicinal Benefits
Adalipca 40 mg/0.8 ml Injection 1's consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.
Directions for Use
Side Effects of Adalipca 40 mg/0.8 ml Injection 1's
Drug Warnings
Adalipca 40 mg/0.8 ml Injection 1's should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), or diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Adalipca 40 mg/0.8 ml Injection 1's to prevent any serious consequences. Adalipca 40 mg/0.8 ml Injection 1's is not recommended for use in children below two years of age as safety and efficacy are not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise